Unilever effectively abandoned its plans to buy GlaxoSmithKline's consumer healthcare business, saying that it would not raise its $68 billion offer that GSK previously rejected https://t.co/yDDWGYZz2P pic.twitter.com/Zmqe2XxuEA— Reuters (@Reuters) January 20, 2022
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)













Quickly


